Comparative effect of angiotensin II type I receptor blockers and calcium ... - 7thSpace Interactive (press release)
Comparative effect of angiotensin II type I receptor blockers and calcium ... 7thSpace Interactive (press release) We evaluated and compared the effects of ARB and CCB monotherapy on clinical laboratory parameters in patients with concomitant hypertension and type 2 diabetes mellitus. Methods: We used data from the Clinical Data Warehouse of Nihon University School ...
Piotr Kloda | People on the Move - Columbus Business First
Piotr Kloda | People on the Move Columbus Business First His special interests include the management of diabetes mellitus type I and II, as well as hypertension. Subscribers Only: Download People on the Move contact information. photo of Piotr Kloda.
DIABETES MELLITUS or SUGAR ? Dreaded Disease! ? Part II - The Labour Spokesman
DIABETES MELLITUS or SUGAR ? Dreaded Disease! ? Part II The Labour Spokesman (1) Type I (one); this results from the body's failure to produce insulin and presently requires the person to inject insulin, also referred to as Insulin Dependent Diabetes Mellitus (IDDM) or Juvenile Diabetes. (3) Gestational Diabetes.
General Insurance: Gaurav Garg - Business Standard
General Insurance: Gaurav Garg Business Standard There could be some general insurance companies that offer covers specially designed for diabetics. However, it is best to engage with the specific insurer to understand the policy scope and coverage related to diabetes mellitus and its complications.
People with Type 2 Diabetes often helped by weight-loss surgery - KVUE
People with Type 2 Diabetes often helped by weight-loss surgery KVUE "I've been doing bariatric surgery for over a decade now and we've always had at least an 85 to 90 percent cure rate for Type 2 Diabetes Mellitus and now, I'm just happy to see that mainstream media is becoming aware," says Dr. Yancey.
Corcept Therapeutics Announces First Quarter Results and Corporate and ... - MarketWatch (press release)
Corcept Therapeutics Announces First Quarter Results and Corporate and ... MarketWatch (press release) ... (FDA) approved it as a once-daily oral treatment of hyperglycemia secondary to endogenous Cushing's syndrome in adult patients with glucose intolerance or diabetes mellitus type 2 who have failed surgery or are not candidates for surgery.
GlaxoSmithKline And Human Genome Science: Don't Bite The Hand That Feeds You - Seeking Alpha
GlaxoSmithKline And Human Genome Science: Don't Bite The Hand That Feeds You Seeking Alpha But the real prizes in the HGSI pipeline may very well be darapladib for chronic coronary heart disease and albiglutide in patients with type 2 diabetes mellitus. And the operational cost synergies from the acquisition have been calculated at $200 ...
Pfizer: Alzheimer's Drugs Will Carry Stock To New Highs In 2013 - Seeking Alpha
Pfizer: Alzheimer's Drugs Will Carry Stock To New Highs In 2013 Seeking Alpha Pfizer has a number of diabetes treatments in Phase I and Phase II trials, most of which aim to treat Diabetes Mellitus-Type 2. Competitor Sanofi (SNY) already has a strong presence with the diabetes audience; 10% of Sanofi's total sales are dependent ...
Weight Loss With Sibutramine Predicts Fewer CV Events Later - Medscape
Weight Loss With Sibutramine Predicts Fewer CV Events Later Medscape The Sibutramine Cardiovascular Outcomes Trial (SCOUT) is the first to evaluate the effects of drug therapy and weight management on CV events in overweight or obese individuals with established CV disease, type 2 diabetes mellitus, or both.
Teaching pre-schoolers healthy lifestyle habits - Channel News Asia
Teaching pre-schoolers healthy lifestyle habits Channel News Asia ... Lee Yung Seng of National University Hospital, among severely overweight children aged 6 to 18 years found that 13 per cent of these children had impaired glucose tolerance (pre-diabetic stage) and 4.5 per cent had type 2 diabetes mellitus.
What our clients and candidates are saying about us: You are the very best I have ever encountered in your field, and I always recommend you to anyone seeking people or a position. - Mel
The #1 Resource for professionals in the Pharmaceutical Advertising, Medical Communications, Healthcare Public Relations, Pharmaceutical Industry, and Biotechnology fields since 1988.